The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
Study Description A5384 is a trial for people who have or might have tuberculous meningitis (TBM). TBM is an infectious disease...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
A5320/V-HICS is an observational, prospective, long-term follow-up study in hepatitis C virus (HCV) monoinfected and HCV/HIV-1...
